The Luveris In Vitro Fertilization Trial

PHASE4TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

May 31, 2013

Study Completion Date

November 30, 2013

Conditions
InfertilityHypothalamic AmenorrheaHyperprolactinemia
Interventions
DRUG

Luveris fixed dose

Luveris 75IU daily throughout ovarian stimulation

DRUG

Luveris increasing dose

Luveris 75IU until estradiol level reaches 250 pg/ml then increasing to 75IU BID for two days, then TID until hCG

Trial Locations (1)

07604

University Reproductive Associates, Hasbrouck Heights

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

EMD Serono

INDUSTRY

lead

University Reproductive Associates

OTHER

NCT00889512 - The Luveris In Vitro Fertilization Trial | Biotech Hunter | Biotech Hunter